Concordare Trials raises an undisclosed amount seed

◆ Announced

25 Aug 2026

◆ Company

◆ Source

◆ The Round

Concordare Trials raised an undisclosed amount in seed funding, announced on 25 August 2026, led by Surface Ventures, with participation from Techstars, Innovation Works, Gaingels. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Concordare Trials

Converts static clinical trial protocol PDFs into structured, interoperable digital formats for clinical research systems. Concordare Trials is based in United States and currently at seed stage, operating in Medtech.

◆ Investors

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links Concordare Trials's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market